Antibiotics plus probiotics for liver infection and prevention
Part of Digestive system, Infections clinical trials.
This study tests whether adding a probiotic to standard antibiotics helps treat an infection in the abdominal fluid of people with cirrhosis (called spontaneous bacterial peritonitis) and prevents it from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have cirrhosis with ascites (fluid in the belly) and a confirmed infection in that fluid.
- You have not taken antibiotics or probiotics for at least one week before starting the study.
- Your liver, kidney, and blood counts are within acceptable ranges.
- You are willing to sign a consent form and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.
This study tests whether taking norfloxacin plus itopride helps prevent another episode of spontaneous bacterial peritonitis (a serious belly infection) in people with cirrhosis and fluid buildup in the abdomen. It compares that combo to norfloxacin alone to see which approach better lowers repeat infections.
This study tests whether adding N-acetylcysteine (an antioxidant supplement) to standard treatment helps fight an infection in the belly fluid of people with liver cirrhosis. It aims to improve recovery and reduce complications.
This study looks at ways to predict a serious infection in the belly fluid (called spontaneous bacterial peritonitis) that can happen in people with cirrhosis. It aims to find easy markers to catch this infection early and help guide treatment.
This study tests a new scoring system to predict if patients with liver cirrhosis and ascites (fluid in the belly) will develop a serious infection called spontaneous bacterial peritonitis. It aims to help doctors identify high-risk patients earlier so they can be monitored more closely.
This study measures how antibiotic drugs called beta-lactams work in people with cirrhosis (liver damage). Researchers will check antibiotic blood levels to see if standard doses are right for cirrhotic patients or need adjustment.
Hear when a new Cirrhosis With Spontaneous Bacterial Peritonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.